GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we treat type 2 diabetes . These new medications help stimulating the body’s own GLP-1 process, https://socialbuzzmaster.com/story7471367/glp-1-a-major-advance-in-glucose-treatment